Evidence map›Paper›PMID 31662500›Full record

ArticleIn vivo (Athens, Greece)

Amelioration of Mucositis in Proton Therapy of Fanconi Anemia Fanca

Thomas J Quinn, Xuanfeng Ding, Xiaoqiang Li, George D Wilson, Katie Buelow, Aranee Sivananthan, Stephanie Thermozier, Andrew Henderson, Michael W Epperly, Darcy Franicola and 4 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Thomas J QuinnDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Xuanfeng DingDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Xiaoqiang LiDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
George D WilsonDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Katie BuelowDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Aranee SivananthanDepartment of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
Stephanie ThermozierDepartment of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
Andrew HendersonDepartment of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
Michael W EpperlyDepartment of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
Darcy FranicolaDepartment of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
Peter WipfDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, U.S.A.
Joel S GreenbergerDepartment of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, U.S.A.
Craig W StevensDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A.
Peyman KabolizadehDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, U.S.A. peyman.kabolizadeh@beaumont.org.
Beaumont Health · USUPMC Hillman Cancer Center · USUniversity of Pittsburgh · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimWe tested JP4-039, a GS-nitroxide radiation damage mitigator in proton therapy of Fanconi anemia (FA) mice. MATERIALS AND

methodsFanca

resultsJP4-039 reduced oral cavity ulceration in Fanca

conclusionJP4-039 protected Fanca

Indexed as

AnimalsCell LineFanconi AnemiaFanconi Anemia Complementation Group A ProteinMesenchymal Stem CellsMiceMucositisNitrogen OxidesProton TherapyRadiation-Protective AgentsRadiation ToleranceFanconi Anemia Complementation Group A ProteinJP4-039Nitrogen OxidesRadiation-Protective AgentsFanconi anemiamucositisprotonradiation protectortoxicity

Identifiers

PMID31662500
PMCPMC6899135
OpenAlexW2984207941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.